Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial
- DOI
- 10.1038/s41467-026-68716-6
- Published
- 2026-01-29
- Container
- Nature Communications
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-026-68716-6,
title = {Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial},
author = {Robin L. Jones and Roman Groisberg and Jean-Yves Blay and Howard Colman and Macarena De La Fuente and Patricia Roxburgh and Mwe Mwe Chao and Hua Tian and Florence Duffaud and Rastislav Bahleda and Brian A. Van Tine},
year = {2026},
journal = {Nature Communications},
doi = {10.1038/s41467-026-68716-6},
url = {https://doi.org/10.1038/s41467-026-68716-6}
}RIS
TY - JOUR TI - Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial AU - Robin L. Jones AU - Roman Groisberg AU - Jean-Yves Blay AU - Howard Colman AU - Macarena De La Fuente AU - Patricia Roxburgh AU - Mwe Mwe Chao AU - Hua Tian AU - Florence Duffaud AU - Rastislav Bahleda AU - Brian A. Van Tine PY - 2026 JO - Nature Communications DO - 10.1038/s41467-026-68716-6 UR - https://doi.org/10.1038/s41467-026-68716-6 ER -
APA
Jones, R. L., Groisberg, R., Blay, J., Colman, H., Fuente, M. D. L., Roxburgh, P., Chao, M. M., Tian, H., Duffaud, F., Bahleda, R., & Tine, B. A. V. (2026). Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial. Nature Communications. https://doi.org/10.1038/s41467-026-68716-6
Source records
- crossref · retrieved 2026-11-10T17:58:03.227Z